Institutional investors hold a majority ownership of DVAX through the 83.06% of the outstanding shares that they control. This interest is also higher than at almost any other company in the Biotechnology industry. Last, during the quarter ended June 2016, these large investors purchased a net $1.3 million shares.
Mutual fund holders
Largest Quarterly Institutional Transactions
Latest Institutional Activity
KINGDON CAPITAL MANAGEMENT LLC Bought 845.3 Thousand shares of Dynavax Technologies Corp